Our Blog

Telix Pharmaceuticals (ASX:TLX) – harnessing radiation to see and treat a range of oncology targets

29 Mar 2021 – Telix Pharmaceuticals Limited (ASX:TLX) Chief Business Officer Dr David Cade talks about the company’s clinical programs, including approvals, partnerships and significant value events anticipated in 2021.


Source: Finance News Network

Share this post